Scrambling to put together a presentation? With Gamma.app, you can transform your raw presentation notes into visually ...

Preclinical presentation highlights key, modality specific, pharmacological differentiations of VG-3927 - - First presentation of topline ...

AVA6000 Phase 1b expansion cohorts enrolling with data targeted for later in 2025AVA6103 IND-enabling studies underway with a Phase 1 trial ...

CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (”CoTec” or the “Company”) is pleased to announce that it has updated its investor presentation to reflect the significant progress the Company has made in ...

This integration enables WeSuite users to seamlessly link one or multiple System Surveyor surveys directly to estimates ...

Sheffield councillors have approved the city’s new crime and disorder reduction strategy, which will be implemented after a ...

Victory Capital Holdings, Inc. (NASDAQ: VCTR) ("Victory Capital" or the "Company") today announced that it has closed on its previously announced transaction with Amundi SA ("Amundi").

There is no immediate rush at Newcastle’s end. While they ideally want to tie Isak down to an extended deal on improved terms ...

Staff from the Securities and Exchange Commission (SEC) issued much needed (and anticipated) relief in the form of two new ...

Relmada Therapeutics pivots to NDV-01 for bladder cancer & Sepranolone for Tourette's. Phase 2 results expected April 2025.